You are currently viewing the abstract.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Abstract
Translational research on endogenous gaseous mediators—nitric oxide, carbon monoxide, and hydrogen sulfide—has exploded over the past decade. Drugs that modulate either the gaseous mediators themselves or their related intracellular signaling pathways are already in use in the clinics, and still more are being tested in preclinical models and clinical trials. Discussed here are the chemical and pharmacological properties that present challenges for the translation of these potentially toxic molecules.
Footnotes
-
Citation: C. Szabo, Gaseotransmitters: New Frontiers for Translational Science. Sci. Transl. Med. 2, 59ps54 (2010).
- Copyright © 2010, American Association for the Advancement of Science
